• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRCA1/2 突变携带者自报诊断性辐射史的可靠性。

Reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers.

机构信息

Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, The Netherlands.

出版信息

Eur J Epidemiol. 2010 Feb;25(2):103-13. doi: 10.1007/s10654-009-9416-x.

DOI:10.1007/s10654-009-9416-x
PMID:20066476
Abstract

We assessed reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers with and without breast cancer. Within the frame-work of the HEBON study, 401 BRCA1/2 mutation carriers completed a baseline (1999-2004) and a follow-up questionnaire (2006-2007). Test-retest reliability of self-reported exposure to chest X-rays, fluoroscopies and mammograms was assessed for the entire study population and by case status.Overall proportion agreement on reporting ever/never exposure was good ([75%), while the corresponding kappa coefficients were between 0.40 and 0.75, indicating at least moderate reliability beyond chance. Reliability of number of exposures was also good ([75%). Proportion agreement on reporting age at first mammogram was low(40%) for exact consistency and moderate (60%) for consistency +/- 1 year. Reliability of age at first mammogram was higher for cases than for unaffected carriers(P\0.001) but this difference disappeared when excluding diagnostic mammograms (P = 0.60). In unaffected carriers proportion agreement on age at last mammogram was 50%. In general, the direction of disagreement on all items was equally distributed. More consistent reporting was mainly determined by a younger age at questionnaire completion. In conclusion, inconsistent self-report of diagnostic radiation by BRCA1/2 mutation carriers was mainly non-differential by disease status.

摘要

我们评估了有和没有乳腺癌的 BRCA1/2 突变携带者自我报告的诊断性辐射史的可靠性。在 HEBON 研究框架内,401 名 BRCA1/2 突变携带者完成了基线(1999-2004 年)和随访问卷(2006-2007 年)。对整个研究人群和病例状态评估了自我报告暴露于胸部 X 光、透视和乳房 X 线照片的测试重测可靠性。报告是否曾经暴露的总体比例一致性良好([75%),而相应的 Kappa 系数在 0.40 到 0.75 之间,表明除了机会之外,至少具有中度可靠性。暴露次数的可靠性也很好([75%)。对于确切的一致性,报告首次乳房 X 线照片的年龄的比例一致性低(40%),对于一致性 +/-1 年,比例一致性适中(60%)。与未受影响的携带者相比,病例的首次乳房 X 线照片年龄的可靠性更高(P\0.001),但在排除诊断性乳房 X 线照片时,这种差异消失(P=0.60)。在未受影响的携带者中,最后一次乳房 X 线照片年龄的比例一致性为 50%。一般来说,所有项目的不一致报告方向分布均匀。更一致的报告主要由问卷完成时的年龄较小决定。总之,BRCA1/2 突变携带者对诊断性辐射的不一致自我报告主要与疾病状态无关。

相似文献

1
Reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers.BRCA1/2 突变携带者自报诊断性辐射史的可靠性。
Eur J Epidemiol. 2010 Feb;25(2):103-13. doi: 10.1007/s10654-009-9416-x.
2
Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers.验证研究表明,BRCA1/2 基因突变携带者自我报告的乳房 X 光检查史不存在差异分类错误。
J Clin Epidemiol. 2011 Dec;64(12):1434-43. doi: 10.1016/j.jclinepi.2011.04.005. Epub 2011 Jul 20.
3
Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers.BRCA1 和 BRCA2 基因突变携带者的诊断性胸部 X 射线和 50 岁前乳腺癌风险。
Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1547-56. doi: 10.1158/1055-9965.EPI-13-0189. Epub 2013 Jul 12.
4
Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.国际BRCA1/2携带者队列研究中胸部X线对BRCA1/2突变携带者患乳腺癌风险的影响:EMBRACE、GENEPSO、GEO-HEBON和IBCCS协作组的报告
J Clin Oncol. 2006 Jul 20;24(21):3361-6. doi: 10.1200/JCO.2005.03.3126. Epub 2006 Jun 26.
5
Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).BRCA1/2 基因突变携带者接受诊断性辐射与乳腺癌风险:回顾性队列研究(GENE-RAD-RISK)。
BMJ. 2012 Sep 6;345:e5660. doi: 10.1136/bmj.e5660.
6
Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study.60岁以上BRCA1和BRCA2突变携带者乳腺癌筛查的相关性和有效性:一项全国队列研究。
Int J Cancer. 2014 Dec 15;135(12):2940-9. doi: 10.1002/ijc.28941. Epub 2014 May 20.
7
Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing.在基于临床的BRCA1/2检测后的女性样本中乳腺癌筛查的应用情况。
Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1115-8.
8
Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.乳腺钼靶筛查与BRCA1和BRCA2突变携带者患乳腺癌的风险:一项前瞻性研究。
Breast Cancer Res Treat. 2014 Aug;147(1):113-8. doi: 10.1007/s10549-014-3063-y. Epub 2014 Aug 1.
9
Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2.乳腺钼靶对携带BRCA1或BRCA2基因突变女性患乳腺癌风险的影响。
Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2311-3. doi: 10.1158/1055-9965.EPI-06-0176.
10
The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan.MRI 筛查 BRCA 突变携带者的临床影响:日本的首次报告。
Breast Cancer. 2019 Sep;26(5):552-561. doi: 10.1007/s12282-019-00955-6. Epub 2019 Feb 28.

引用本文的文献

1
Lack of validity of self-reported mammography data.自我报告的乳房X光检查数据缺乏有效性。
Fam Med Community Health. 2019 Jan 29;7(1):e000096. doi: 10.1136/fmch-2018-000096. eCollection 2019.
2
Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers.BRCA1 和 BRCA2 基因突变携带者的诊断性胸部 X 射线和 50 岁前乳腺癌风险。
Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1547-56. doi: 10.1158/1055-9965.EPI-13-0189. Epub 2013 Jul 12.
3
Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).

本文引用的文献

1
Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers.体力活动与 BRCA1/2 基因突变携带者乳腺癌风险的关系。
Breast Cancer Res Treat. 2010 Feb;120(1):235-44. doi: 10.1007/s10549-009-0476-0. Epub 2009 Aug 13.
2
Accuracy of self-reports of Pap and mammography screening compared to medical record: a meta-analysis.与病历相比,巴氏涂片检查和乳房X线筛查自我报告的准确性:一项荟萃分析。
Cancer Causes Control. 2009 Feb;20(1):1-13. doi: 10.1007/s10552-008-9228-4. Epub 2008 Sep 19.
3
Cancer risks from diagnostic radiology.
BRCA1/2 基因突变携带者接受诊断性辐射与乳腺癌风险:回顾性队列研究(GENE-RAD-RISK)。
BMJ. 2012 Sep 6;345:e5660. doi: 10.1136/bmj.e5660.
诊断性放射学带来的癌症风险。
Br J Radiol. 2008 May;81(965):362-78. doi: 10.1259/bjr/01948454.
4
Early radiation exposures and BRCA1-associated breast cancer in young women from Poland.波兰年轻女性的早期辐射暴露与BRCA1相关乳腺癌
Breast Cancer Res Treat. 2008 Dec;112(3):581-4. doi: 10.1007/s10549-008-9892-9. Epub 2008 Jan 18.
5
Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive.荷兰的病理学数据库建设与生物样本库建设,PALGA发挥核心作用,PALGA是全国性的组织病理学和细胞病理学数据网络及档案库。
Cell Oncol. 2007;29(1):19-24. doi: 10.1155/2007/971816.
6
Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2.乳腺钼靶对携带BRCA1或BRCA2基因突变女性患乳腺癌风险的影响。
Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2311-3. doi: 10.1158/1055-9965.EPI-06-0176.
7
Cellular functions of the BRCA tumour-suppressor proteins.BRCA肿瘤抑制蛋白的细胞功能。
Biochem Soc Trans. 2006 Nov;34(Pt 5):633-45. doi: 10.1042/BST0340633.
8
Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.国际BRCA1/2携带者队列研究中胸部X线对BRCA1/2突变携带者患乳腺癌风险的影响:EMBRACE、GENEPSO、GEO-HEBON和IBCCS协作组的报告
J Clin Oncol. 2006 Jul 20;24(21):3361-6. doi: 10.1200/JCO.2005.03.3126. Epub 2006 Jun 26.
9
Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.BRCA1和BRCA2突变携带者的乳腺钼靶筛查与乳腺癌风险:一项病例对照研究。
Lancet Oncol. 2006 May;7(5):402-6. doi: 10.1016/S1470-2045(06)70624-6.
10
Test-retest reliability of self-reported mammography in women veterans.退伍女兵自我报告的乳房X光检查的重测信度。
Prev Med. 2006 Apr;42(4):320-6. doi: 10.1016/j.ypmed.2005.12.001. Epub 2006 Jan 24.